MedTrace Logo

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

NCT06914596 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-06-24

No results posted yet for this study

Summary

The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatment after.

Conditions

  • Periodontitis (Stage 3)

Interventions

DEVICE

Emanate Perio PODS

Emanate Perio PODS used 2x/day for 30 minutes use

Sponsors & Collaborators

  • Emanate Biomedical Inc.

    collaborator INDUSTRY

  • McGuire Institute

    lead INDUSTRY

Principal Investigators

  • Jarret Fass · Emanate Biomedical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-19
Primary Completion
2026-12-30
Completion
2027-01-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06914596 on ClinicalTrials.gov